Harmony Biosciences Holdings (HRMY) Competitor Comparison
We are evaluating the key criteria listed to compare Harmony Biosciences Holdings (HRMY) against its competitors in the Biotechnology industry.
Market Capitalization
85 / 368Gross Profits
20 / 278Total Revenue
24 / 300EBITDA
11 / 337Free Cashflow
12 / 352Quick Ratio
224 / 357Earnings per Share
13 / 359Dividend yield
0 / 6Total Cash
83 / 358Performance 3 years
117 / 368Performance 5 years
148 / 368Performance 10 years
110 / 368Linearity 3 years
20 / 368Linearity 5 years
19 / 368Linearity 10 years
6 / 368Total Rank
141 / 368Dividend Rank
145 / 368Valuation Rank
22 / 368Piotroski Rank
15 / 368Muliplier Rank
354 / 368Free Cashflow - HRMY ranking 12 / 352
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.